Groeschel v. Array Biopharma, Inc

Court

District Court, D. Colorado (D. Colo.)
Official Court Website →

Assigned judge

Christine M. Arguello · 1,697 cases in index

Docket number

1:19-cv-01960

Cause

15:0078m(a) - Securities Exchange Act
15 U.S.C. § 78m

Nature of suit

850 Securities, Commodities, Exchange
Alleged violations of federal securities or commodities laws.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

07/08/2019

Date terminated

09/25/2019

1,327 Securities / Commodities cases in this court are indexed here.

Parties

• plaintiff · Groeschel · 4 cases
• defendant · Array Biopharma Inc · 15 cases

Part of a Larger Litigation Pattern

This is one of 16 Securities / Commodities cases in our index naming Array Biopharma Inc — a possible mass-tort or coordinated-litigation cluster.

• Dembitzer v. Array BioPharma Inc
  District Court, D. ColoradoFiled 07/12/2019
• Wescott v. Array BioPharma Inc
  District Court, D. DelawareFiled 07/12/2019
• Guerrero v. Array BioPharma Inc
  District Court, D. ColoradoFiled 07/11/2019
• Noel v. Array Biopharma Inc
  District Court, D. ColoradoFiled 07/03/2019
• Kent v. Array BioPharma Inc
  District Court, D. DelawareFiled 07/01/2019
• Nauman v. Array Biopharma Inc
  District Court, D. ColoradoFiled 11/28/2017

About Securities / Commodities Lawsuits

Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

Frequently Asked Questions

What is Groeschel v. Array Biopharma, Inc?

Groeschel v. Array Biopharma, Inc is a federal securities / commodities lawsuit filed on 07/08/2019 in the District Court, D. Colorado. The case was terminated on 09/25/2019. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

What type of case is this?

It is classified as “Securities / Commodities” under the federal nature-of-suit system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

What court is the case in?

The case is in the District Court, D. Colorado, docket number 1:19-cv-01960.

When was the case filed?

Groeschel v. Array Biopharma, Inc was filed on 07/08/2019. It was terminated on 09/25/2019.

What law is the case brought under?

The docket lists the cause as 15 U.S.C. § 78m.